These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1077 related articles for article (PubMed ID: 2832130)
21. Further studies on the anti-neoplastic activity of 3 beta-hydroxy-13 alpha-amino-13,17-seco-5 alpha-androstan-17-oic-13,17-lactam [p-[bis(2-chloroethyl)amino]-phenyl]acetate (NSC 290205). Catsoulacos P Cancer Lett; 1984 Mar; 22(2):199-202. PubMed ID: 6704948 [TBL] [Abstract][Full Text] [Related]
22. Bifunctional constructs of aspirin and ibuprofen (non-steroidal anti-inflammatory drugs; NSAIDs) that express antibacterial and alkylation activities. Bartzatt R; Cirillo SL; Cirillo JD; Donigan L Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):273-82. PubMed ID: 12533193 [TBL] [Abstract][Full Text] [Related]
23. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice. Cantrell JE; Green D; Schein PS Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728 [TBL] [Abstract][Full Text] [Related]
24. Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide. Roboz J; Jiang J; Holland JF; Bekesi JG Cancer Res; 1997 Nov; 57(21):4795-802. PubMed ID: 9354441 [TBL] [Abstract][Full Text] [Related]
25. Self-immolative nitrogen mustard prodrugs for suicide gene therapy. Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Spooner R; Davies L; Marais R; Springer CJ J Med Chem; 1998 Dec; 41(26):5297-309. PubMed ID: 9857097 [TBL] [Abstract][Full Text] [Related]
28. Transport of L-tyrosine by B16/F10 melanoma cells: the effect of the intracellular content of other amino acids. Jara JR; Martinez-Liarte JH; Solano F; PeƱafiel R J Cell Sci; 1990 Nov; 97 ( Pt 3)():479-85. PubMed ID: 2074267 [TBL] [Abstract][Full Text] [Related]
29. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma. Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474 [TBL] [Abstract][Full Text] [Related]
30. Antitumor effect of N alpha-benzyloxycarbonyl-N,N-bis-(2-halogenethyl)-hydrazide derivatives of amino acids. Karaivanova MH; Zakhariev SG; Golovinsky EV Neoplasma; 1980; 27(2):137-42. PubMed ID: 7393353 [TBL] [Abstract][Full Text] [Related]
31. Conjugated system of homo-aza-steroidal esters in cancer chemotherapy. Catsoulacos P; Catsoulacos D Anticancer Res; 1994; 14(6B):2525-8. PubMed ID: 7872677 [TBL] [Abstract][Full Text] [Related]
32. Neutral amino acid transport pathways in uptake of L-thyroxine by Ehrlich ascites cells. Stitzer LK; Jacquez JA Am J Physiol; 1975 Jul; 229(1):172-7. PubMed ID: 1170764 [TBL] [Abstract][Full Text] [Related]
33. Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems. Niculescu-Duvaz I; Scanlon I; Niculescu-Duvaz D; Friedlos F; Martin J; Marais R; Springer CJ J Med Chem; 2004 May; 47(10):2651-8. PubMed ID: 15115406 [TBL] [Abstract][Full Text] [Related]
34. 3-O-methyl-6-18F-fluoro-L-dopa, a new tumor imaging agent: investigation of transport mechanism in vitro. Bergmann R; Pietzsch J; Fuechtner F; Pawelke B; Beuthien-Baumann B; Johannsen B; Kotzerke J J Nucl Med; 2004 Dec; 45(12):2116-22. PubMed ID: 15585490 [TBL] [Abstract][Full Text] [Related]
35. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia. Zeller WJ; Schreiber J; Petru E; Eisenbrand G Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608 [TBL] [Abstract][Full Text] [Related]
36. Cell density and amino acid transport in 3T3, SV3T3, and SV3T3 revertant cells. Borghetti AF; Piedimonte G; Tramacere M; Severini A; Ghiringhelli P; Guidotti GG J Cell Physiol; 1980 Oct; 105(1):39-49. PubMed ID: 7430266 [TBL] [Abstract][Full Text] [Related]
37. Effects of a new bifunctional alkylating agent (PTT-119) on in vitro growth of human cell lines and normal myeloid progenitors (CFU-GM). Lemoli RM; Visani G; Tosi P; Mazza P; Motta MR; Rizzi S; Zinzani PL; Poluzzi C; Gherlinzoni F; Tura S Haematologica; 1988; 73(3):195-200. PubMed ID: 3139515 [No Abstract] [Full Text] [Related]
38. Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184. Moy BC; Petzold GL; Badiner GJ; Kelly RC; Aristoff PA; Adams EG; Li LH; Bhuyan BK Cancer Res; 1990 Apr; 50(8):2485-92. PubMed ID: 2317831 [TBL] [Abstract][Full Text] [Related]
39. Targeting glutamine transport to suppress melanoma cell growth. Wang Q; Beaumont KA; Otte NJ; Font J; Bailey CG; van Geldermalsen M; Sharp DM; Tiffen JC; Ryan RM; Jormakka M; Haass NK; Rasko JE; Holst J Int J Cancer; 2014 Sep; 135(5):1060-71. PubMed ID: 24531984 [TBL] [Abstract][Full Text] [Related]
40. Multicomponent analysis of amino acid transport in human lymphocytes. Diminished L-system transport in chronic leukemic B lymphocytes. Segel GB; Simon W; Lichtman MA J Clin Invest; 1984 Jul; 74(1):17-24. PubMed ID: 6610691 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]